Evidence map›Paper›PMID 27153553›Full record

ArticleOncotarget2016

Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China.

Gongjian Zhu, Haixiang Su, Lingeng Lu, Hongyun Guo, Zhaohui Chen, Zhen Sun, Ruixia Song, Xiaomin Wang, Haining Li, Zhiping Wang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Modification ofInternational journal of environmental research and public health · 2020
    Article
  8. Oxidative medicine and cellular longevity · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Gongjian ZhuSchool of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, China.
Haixiang SuGansu Provincial Academy of Medical Sciences, Gansu Provincial Cancer Hospital, Lanzhou, Gansu 730050, China.
Lingeng LuDepartment of Chronic Disease Epidemiology, Yale School of Public Health, School of Medicine, Yale Cancer Center, Yale University, New Haven, CT 06520-8034, USA.
Hongyun GuoGansu Provincial Academy of Medical Sciences, Gansu Provincial Cancer Hospital, Lanzhou, Gansu 730050, China.
Zhaohui ChenInstitute of Urology, the Second Hospital of Lanzhou University, Lanzhou, Gansu 730000, China.
Zhen SunSchool of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, China.
Ruixia SongInstitute of Urology, the Second Hospital of Lanzhou University, Lanzhou, Gansu 730000, China.
Xiaomin WangDepartment of Internal Medicine, Xigu District of Lanzhou City People's Hospital, Lanzhou, Gansu 730050, China.
Haining LiGansu Provincial Academy of Medical Sciences, Gansu Provincial Cancer Hospital, Lanzhou, Gansu 730050, China.
Zhiping WangInstitute of Urology, the Second Hospital of Lanzhou University, Lanzhou, Gansu 730000, China.
Lanzhou University Second Hospital · CNLanzhou University · CNYale Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBalance of DNA damage and proper repair plays an important role in progression of bladder cancer. Here we aimed to assess the associations of nineteen polymorphisms from seven DNA repair-associated genes (PRAP1, OGG1, APEX1, MUTYH, XRCC1, XRCC2 and XRCC3) with bladder cancer and their interactions in the disease in a Han Chinese population. METHODOLOGY/PRINCIPAL

findingsA chip-based TaqMan genotyping for the candidate genes was performed on 227 bladder cancer patients and 260 healthy controls. APEX1 rs3136817, MUTYH rs3219493, three SNPs (rs3213356, rs25487 and rs1799782) in XRCC1, and three SNPs (rs1799794, rs861531 and rs861530) in XRCC3 showed significant associations with the risk of bladder cancer. In haplotype analysis, elevated risks of bladder cancer were observed in those with either haplotype GT (OR = 1.56, P = 0.003) of APEX1, or GGGTC (OR = 2.05, P = 0.002) of XRCC1, whereas decreased risks were in individuals with either GCGCC (OR = 0.40, P = 0.001), or GCGTT (OR = 0.60, = 0.005) of XRCC1, or CCC (OR = 0.65, P = 0.004) of MUTYH, or TTTAT (OR = 0.36, P = 0.009) of XRCC3. Interaction analysis showed that the two-loci model (rs1799794 and rs861530) was the best with the maximal testing accuracy of 0.701, and the maximal 100% cross-validation consistency (P = 0.001).

conclusionsPolymorphisms and haplotypes of DNA repair genes are associated with the risk of bladder cancer, and of which the SNPs (rs1799794 and rs861530) in XRCC3 gene might be two major loci in relation to the susceptibility to bladder cancer in a northwest Chinese population.

Indexed as

Polymorphism, Single NucleotideAdultAgedAsian PeopleCase-Control StudiesChinaDNA RepairFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHaplotypesHumansMaleMiddle AgedRisk Factorsbladder cancerDNA repairgene interactionpolymorphisms

Identifiers

PMID27153553
PMCPMC5058763
OpenAlexW2346018505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.